Diabetes-related thrombotic risk factors include: Hyperglycaemia-induced endothelial dysfunction , promoting a prothrombotic state Increased platelet reactivity and aggregation Elevated levels of clotting factors including fibrinogen and von Willebrand factor Chronic inflammation with raised inflammatory markers Impaired fibrinolysis , reducing the body's ability to break down clots Obesity independently increases thrombotic risk through multiple mechanisms
The advantage of solid phase synthesis is that the initial reactants and products are all connected to the solid phase carrier, so it can All the reactions are carried out in the medium, which is convenient for automatic operation, and high yield products can be obtained by adding excess reactants, and t
Supports multiple simultaneous medications with separate schedules for each
Potential risks include: Overdosing, which can result in severe nausea, vomiting, or hypoglycemia
In this regard, liraglutide (RR 0.5474 [95% CI 0.0350, 8.5718
The MHRA assesses the drug's quality, safety, and efficacy